Farm Industry News

Novozymes expands biologicals with EMD purchase

Novozymes is branching further into the U.S. biological market with the purchase of EMD/Merck Crop BioScience. David Fox, Novozymes marketing manager, explains why there's a growth in biologicals for the farm market. To view more videos, visit http://farmindustrynews.com/media

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish